LabCompass

Theodore L. Wagener

Medicine · The Ohio State University

Mid career · publishing since 2006Rising activity

Publications

160

Citations

2,285

Est. group size

~25

Recurring co-author estimate

Active years

20

Publishing since 2006

Research summary
AI-generated

Theodore L. Wagener's research focuses on tobacco and nicotine products, particularly e-cigarettes, heated tobacco products, and menthol cigarettes, and how they affect smoking behavior, addiction, and cessation. His work often involves clinical trials and surveys examining how product features (like flavors, nicotine levels, and pricing) influence use patterns, harm reduction potential, and quitting success, with attention to disparities across racial and ethnic groups. He also studies related topics such as cannabis use and psilocybin-assisted therapy for depression.

E-cigarettes and vaping behaviorSmoking cessation and harm reductionNicotine and tobacco regulation policyHealth disparities in substance useBehavioral and clinical trials on addiction

Publication output has been fairly steady over the past decade (roughly 10-16 papers per year) with a notable spike to 32 publications in 2023 before returning to a more typical pace.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 13.6/year recently
2017: 9 publications172018: 11 publications182019: 16 publications192020: 13 publications202021: 11 publications212022: 11 publications222023: 32 publications32232024: 15 publications242025: 10 publications2526
Recent publications
Publishes in
  • Addictive Behaviors×12
  • Tobacco Control×11
  • Nicotine & Tobacco Research×9
  • PLoS ONE×6
  • International Journal of Environmental Research and Public Health×5
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile